To facilitate molecular analyses of a previously uncharacterized gene involved in alanine synthesis, attempts were made to clone the wild-type allele of this gene, alaA, with a mini-Mu plasmid element used for in vivo cloning. Seventy-six independent Ala' plasmids were isolated and characterized. Physiological, enzymological, and restriction endonuclease analyses indicated that three different genes, none of them alaA, were cloned. These genes were avtA+, which encodes the alanine-valine transaminase (transaminase C); tyrB+, which encodes the tyrosine-repressible transaminase (transaminase D); and a previously undescribed gene, called alaB, which encodes an alanine-glutamate transaminase.
Traditionally, genetic and physiological analyses of nullactivity mutations have been used to help elucidate biosynthetic pathways in microorganisms. When more than one enzyme catalyzes any particular step, however, such mutations are difficult but not impossible to obtain (see, for example, references 7, 14, 16, 19, and 20) . Despite the power of physiological genetics, no tight L-alanine auxotrophs have been reported, probably because this simple amino acid can be synthesized from pyruvate by a number of different transaminases. Mutations responsible for a leaky requirement for either alanine or valine, called alaA, have, however, been isolated by transposon mutagenesis in both Escherichia coli and Salmonella typhimurium (3; W. Whalen, Ph.D. thesis, The University of Connecticut, Storrs, 1984) .
To identify the enzyme encoded by alaA and to begin a molecular genetic analysis of this apparently new gene, we attempted to clone alaA+ on a multicopy plasmid by using a mini-Mu plasmid element (8) as the in vivo cloning vector. In the results presented below, 76 independent Ala' plasmids were characterized, but none of these carried alaA+. Instead, three transaminase genes were cloned. One of these genes, alaB, has not been described previously.
MATERIALS AND METHODS
Chemicals and media. Lennox (L) complex medium and Vogel and Bonner glucose-medium E salts were used as described elsewhere (2) . Medium E was supplemented at the following levels where required: L-alanine (0.23 mM), Laspartate (0.13 mM), L-isoleucine (0.15 mM), L-leucine (0.15 mM), L-phenylalanine (0.24 mM), L-proline (0.26 mM), thiamine (6 FM), thymine (0.079 mM), L-tryptophan (0.10 mM), L-tyrosine (0.11 mM), and L-valine (0.17 mM). Chloramphenicol (20 ,ug/ml) or 3-chloro-L-alanine (3-CA) (1 mM) was added where indicated. Specialized chemicals were purchased from Sigma Chemical Co., St. Louis, Mo. Restriction endonucleases and the DNA size markers were purchased from Bethesda Research Laboratories, Gaithersburg, Md., and agarose was purchased from FMC Corp., Rockland, Maine.
Enzyme assays. Cells were grown in appropriately supplemented medium E, and crude extracts were prepared and * Corresponding author. assayed as described previously (20) , except that chloramphenicol was added to the medium to maintain the mini-Mu plasmid. Isoleucine-glutamate transaminase activity (transaminase B, encoded by ilvE) was measured by using isoleucine as the amino donor in 2-keto-3-methylvalerate production (2) . Alanine-valine transaminase activity (transaminase C, encoded by avtA) was measured by using alanine as the amino donor in pyruvate production (12, 20) . Tyrosine-glutamate transaminase activity (principally transaminase D, encoded by tyrB) was measured by using tyrosine as the amino donor in p-hydroxyphenylpyruvate production (5) . Aspartate-glutamate transaminase activity (principally transaminase A, encoded by aspC) and alanineglutamate transaminase activity (encoded by alaB, described below, and possibly other genes) were measured in a coupled reaction by using glutamate as the amino donor and the appropriate keto acid as the amino receptor (7) .
Bacterial strains, phage, and plasmids. Mini-Mu-Mu cts double lysogens were constructed as described elsewhere (17) . Cloning of quasi-random DNA fragments was carried out in vivo with a mini-Mu phage, Mu dII4042 (8), as depicted in Fig. 1 and described in greater detail elsewhere (8, 17, 18) . Mu dII4042 is a short (16.7-kilobase [kb] ) derivative of phage Mu (37.5 kb) that has Mu genes A and B, the two Mu ends needed for replication and transposition, the replication origin of the multicopy plasmid P15A, and the chloramphenicol (cam) resistance gene of Tn9 (8) . Chromosomal segments up to about 20 kb in length can be cloned with Mu dII4042, but most segments are 5 to 13 kb (8, 18 ; this study). Because Mu dII4042 has a multicopy plasmid replication origin, it is not normally found inserted into the chromosome (8, 17) . Isolation and characterization of Mu dII4042 plasitids carrying chromosomal genes. Lysates were prepared ill the Mu cts-Mu dII4042 double lysogen XPh43 Mu cts/pEG109 or CBK801 Mu cts/pEG109 and used to infect CBK76OMucts as described elsewhere (17) . Cells were plated at appropriate dilutions on medium E plates containing thymine, thiamine, proline, isoleucine, and chloramphenicol (selecting Camr AlaNVal+ transductants) or on the same medium plus 3-CA (selecting Camr Ala/Val' 3-CAr transductants). After incu-, bation at 30°C for 3 to 5 days, isolated colonies were picked and purified on the same medium.
Ala/Val+ revertants arise in CBK760 (which has a partial alanine or valine requirement) at a frequency of about 10-, whereas mini-Mu plasmids carrying a given gene can be found at a frequency of 10-8 to 10-5 (8, 17) . The recovery of unwanted chromosomal mutations was reduced by adding to the medium either chloramphenicol, which killed 1ecipients that lacked an established mini-Mu plasmid, or 3-CA, which reduced background growth.
Mini-Mu plasmids are rapidly lost if not maintained by selection (8, 17) . To determine whether the selected phenotype was due to a plasmid-borne gene or to either generalized transduction or a chromosomal mutation (with the independent acquisition of a mini-Mu plasmid), cells from Camr colonies were streaked on L agar lacking chloramphenicol, and the resulting colonies were screened for loss of resistance and for growth requirements: colonies in which the Ala/Val' determinant was plasmid-borne gave rise to Cams segregants that had regained the alanine requirement.
Restriction analysis bf mini-Mu plasmids. Cells were grown with aeration overnight in L broth plus chloramphenicol to prevent plasmid loss. Plasmid DNA was obtained by a rapid alkaline extraction procedure (11) and digested with restriction endonucleases as specified by the supplier. The digests were analyzed by electrophoresis in 0.75% agarose. Fragment sizes were estimated by comparison with fragments of the DNA gel marker (1-kb ladder) and, where available, with published data. Mu cts were isolated. Large colony transductants were found on medium containing 3-CA, and both large and small colony transductants were found on medium lacking 3-CA. Seventy of 72 large-colony transductants were found to be isoleucine independent, whereas two retained the isoleucine requirement of the recipient strain. All large-colony transductants were 3-CAr regardless of which medium they were isolated on. All of 16 small-colony transductants required isoleucine, were 3-CA3, and made large colonies on alanineor valine-supplemented medium. Cam' (plasmid-free) segregants of 12 large-colony transductants and of 4 of 16 smallcolony transductants were found to regain the parental phenotype, indicating that their properties were due to plasmid-borne genes.
RESULTS
(i) Characterization of plasmids from Isoleucine-independent transductants. Because ilvE encodes transaminase B, the only transaminase previously known to catalyze isoleucine biosynthesis in vivo (15) , and both the donor and recipient have ilvE mutations, the isoleucine independence of most large-colony Ala/Val' plasmid transductants indicated the recruitment of an enzyme not previously implicated in isoleucine synthesis. All of 26 isoleucine-independent transductants tested had elevated transaminase C activity, but no transaminase B activity ( Table 2 ; data not shown), like a strain with an avtA+ plasmid ( Table 2 ). In confirmation, restriction mapping showed overlaps between these plasmids and bona fide avtA+ plasmids ( Fig. 2A) (18) . These data suggested that the increased levels of transaminase C obtained when avtA+ was on a multicopy plasmid resulted in synthesis of physiologically significant levels of isoleucine.
(11) Characterization of plasfidsrom large isoleucinerequiring transductants. Neither transductant [CBK760 (pIFO56) or CBK760(pIF063)] had detectable transaminase B activity or elevated transaminase C activity, alt,hough both had a significant elevation in tyrosine-glutamate transaminase activity and a small elevation in aspartate-glutamate transaminase activity (Table 2 ). Since tyrosine is the preferred substrate for transaminase D (encoded by tyrB), and aspartate is the preferred substrate for transaminase A (encoded by aspC) (7), it was likely that tyrB had been cloned even though neither transaminase had previously been implicated in either alanine or valine synthesis.
The restriction maps of these presumptive tyrB+ plasmids (pIF056 and pIF063) overlapped those of plasmids that had been isolated by complementation of tyrB mutants (Fig. 2B) (6, 10).
(il) Characterization of plasmids from small esodecinerequiring plasmid transductants. The four transductants that carried the plasmid-borne Ala/Val' determinant had 5-to 10-fold elevated levels of alanine-glutamate transaminase activity and no significant elevation in transaminase A, B, C, or D activities (Table 2 ; data not shown). Therefore, the cloned gene in these four transductants encodes an alanineglutamate' transaminase. The restriction maps of these plasmids are shown in Fig. 2C .
The slow growth of these plasmid-containing strains suggested that a different gene, which can only partially suppress alaA, was cloned. The possibility that alaA+ was cloned but that it or a linked gene was deleterious was excluded because strains containing these plasmids grew normally if alanine or valine was added to the medium. Therefore, the cloned gene encoded an enzyme that can participate in alanine synthesis, but only suboptimally. This gene was named alaB. The alaB+ plasmid transductants were 3-CA3, indicating that the enzyme encoded by alaB, unlike the enzymes encoded by jivE, avtA, and tyrB, does not confer 3-CA resistance when overproduced.
To determine whether the alanine-glutamate transaminase encoded by alaB catalyzes either valine or leucine synthesis when overproduced, pIF061 was transformed into CBK741 (which cannot transaminate valine or isoleucine) and into CBK717 (which cannot transaminate leucine or isoleucine). while the absence of alaA+ plasmids raised the possibility that either alaA+ or a gene linked to alaA is harmful when DISCUSSION present in multiple copies. A seemingly analogous case of study was initially undertaken to clone alaA+ multicopy suppression coupled with the absence of true plasmid for molecular genetic analyses of this complementing plasmids involves ginP, which was lethal on al was not achieved because alaA+ was not a multicopy plasmid (13 (Fig. 1) . This deviation from random Mu EH B insertion appears to be regional rather than site specific, 3 ( 4 since for any one gene the endpoints of cloned fragments are quite random (18) (Fig. 2) The cloning of three genes other than alaA illustrates the ability of an excess of the product of one gene to compensate for a defect in a nonallelic gene and provides a valuable approach for analyzing metabolic pathways. Overproduction of an enzyme in vivo, for example, by cloning the corresponding gene, can lead to significant levels of a normally minor enzyme activity. (i) Suppression of the isoleucine requirement of ilvE mutants (see Results) suggests that at high levels, transaminase C can recruit isoleucine as an amino donor in alanine and valine biosynthesis. (ii) In tyrB+ plasmid strains, excess transaminase D may function in alanine or valine synthesis directly or indirectly by increasing the pool of leucine or another amino acid, which then serves as the amino donor in transaminase C-catalyzed alanine biosynthesis. (iii) Since the alanine or valine requirement of CBK760 was only partially suppressed in alaB+ plasmid strains despite their high alanine-glutamate transarfinase activity in vitro (Table 2) , the alanine-glutamate transaminase encoded by alaB may require the alaA product to function efficiently in vivo.
The present results, showing that a cloned wild-type gene which suppresses the mutant phenotype may not be allelic to the original lesion, illustrates the need for caution in cloning studies. Since most large-colony plasmid transductants carried avtA+, one might have concluded that they actually carried alaA+. This possibility was excluded here because bona fide avtA+ plasmids had been characterized previously (18) and because nonoverlapping plasmids that i-conferred three distinct phenotypes were obtained. In most cloning studies, however, only one or a few plasmids are isolated, and different phenotypic classes cannot be so sensitively distinguished.
